New EU clinical network launched to accelerate trialling Covid-19 vaccines Network to act as rapid response single entry-point for all stakeholders Ireland is one of 21 member countries participating in a new European Union (EU) vaccine clinical network which has been launched to accelerate the trialling of Covid-19 vaccines, writes Maureen Browne. VACCELERATE, the European Corona Vaccine Trial Accelerator Platform, will be the pan-European backbone accelerating Phase 2 and 3 Covid-19 vaccine trials, connecting all stakeholders involved in vaccine development and providing a platform for clinical trial design and conduct. Irish Partners are University College Dublin (UCD) and NUI Galway, led from UCD by infectious diseases expert